MedTrace Logo

A Safety Study of Balsamic Bactrim in Pediatric Participants With Acute Bronchitis

NCT02879981 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 51

Last updated 2019-12-13

No results posted yet for this study

Summary

This pilot, multicentric and observational study will assess the safety of sulfamethoxazole + trimethoprim + guaifenesin (Balsamic Bactrim) in pediatric participants with acute bronchitis. Administration of treatment will be according to treating physician's recommendation under local labeling.

Conditions

  • Bronchitis

Interventions

DRUG

Guaifenesin

Administration of treatment will be according to treating physician's recommendation under local labeling. The study protocol does not specify any treatment regimen.

DRUG

Sulfamethoxazole

Administration of treatment will be according to treating physician's recommendation under local labeling. The study protocol does not specify any treatment regimen.

DRUG

Trimethoprim

Administration of treatment will be according to treating physician's recommendation under local labeling. The study protocol does not specify any treatment regimen.

Sponsors & Collaborators

Principal Investigators

  • Clinical Trials · Hoffmann-La Roche

Eligibility

Min Age
4 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-10
Primary Completion
2017-08-28
Completion
2017-08-28

Countries

  • Peru

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02879981 on ClinicalTrials.gov